PATRICIA INGOLD: Open Payments
NPI 1700893963 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 16 payments from 9 companies in 2025. Trend: 2023 $324 · 2024 $48 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| Amgen Inc. | 4 | $63 |
| Medtronic, Inc. | 1 | $38 |
| ABBVIE INC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Abbott Laboratories | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: REPATHA, Ozempic, MINIMED 780G, Rybelsus, GARDASIL 9, FREESTYLE LIBRE 3, REXULTI, GEMTESA.
Industry payments across GA — which companies pay providers there.
